Comparative outcomes after percutaneous coronary intervention among black and white patients treated at US Veterans Affairs hospitals

JAMA Cardiology

Volumn 2, Issue 9, 2017, Pages 967-975

  Kobayashi, Taisei ^a,b   Glorioso, Thomas J ^c,d,e,f   Armstrong, Ehrin J ^c,d,e   Maddox, Thomas M ^c,d,e,f   Plomondon, Mary E ^c,d,e,f   Grunwald, Gary K ^c,d,e,f   Bradley, Steven M ^c,d,e   Tsai, Thomas T ^c,d,e   Waldo, Stephen W ^c,d,e   Rao, Sunil V ^f   Banerjee, Subhash ^g,h   Nallamothu, Brahmajee K ^i,j   Bhatt, Deepak L ^a,k,l,m,n   Rene, A Garvey ^a,b   Wilensky, Robert L ^a,b   Groeneveld, Peter W ^a,b   Giri, Jay ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Evaluative Research Center   (United States)

^c Veterans Affairs Eastern Colorado Health Care System   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e Department of Medicine   (United States)

^f Food Science and Human Nutrition   (United States)

^g DURHAM VA MEDICAL CENTER   (United States)

^h DUKE UNIVERSITY   (United States)

ⁱ Veterans Affairs North Texas Health Care System   (United States)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^k VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^l UNIVERSITY OF MICHIGAN   (United States)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁿ HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLACK PERSON; BLOOD TRANSFUSION; CAUCASIAN; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FLOW MEASUREMENT; FLUOROSCOPY; HEALTH CARE; HEART INFARCTION; HOSPITAL CARE; HOSPITAL READMISSION; HUMAN; INTRAVASCULAR ULTRASOUND; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PUBLIC HOSPITAL; SEX DIFFERENCE; TREATMENT OUTCOME; UNITED STATES; ACUTE CORONARY SYNDROME; AFRICAN AMERICAN; CORONARY ARTERY OBSTRUCTION; FRACTIONAL FLOW RESERVE; GOVERNMENT; INTERVENTIONAL ULTRASONOGRAPHY; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ODDS RATIO; POSTOPERATIVE CARE; PROCEDURES; RADIAL ARTERY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; STENT; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; AFRICAN AMERICANS; AGED; ANGINA, STABLE; ANGINA, UNSTABLE; BLOOD TRANSFUSION; CORONARY ARTERY DISEASE; CORONARY STENOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HOSPITALS, VETERANS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; NON-ST ELEVATED MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT READMISSION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE CARE; RADIAL ARTERY; ST ELEVATION MYOCARDIAL INFARCTION; STENTS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 85032641375     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2017.2180     Document Type: Article

References (49)

1. Chen J, Rathore SS, Radford MJ, Wang Y, Krumholz HM. Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med. 2001;344(19):1443-1449.
2. McBean AM, Warren JL, Babish JD. Continuing differences in the rates of percutaneous transluminal coronary angioplasty and coronary artery bypass graft surgery between elderly black and white Medicare beneficiaries. Am Heart J. 1994;127(2):287-295.
3. Whittle J, Kressin NR, Peterson ED, et al. Racial differences in prevalence of coronary obstructions among men with positive nuclear imaging studies. J Am Coll Cardiol. 2006;47(10):2034-2041.
4. Giles WH, Anda RF, Casper ML, Escobedo LG, Taylor HA. Race and sex differences in rates of invasive cardiac procedures in US hospitals: data from the National Hospital Discharge Survey. Arch Intern Med. 1995;155(3):318-324.
5. Gornick ME, Eggers PW, Reilly TW, et al. Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med. 1996; 335(11):791-799.
6. Chen MS, Bhatt DL, Chew DP, Moliterno DJ, Ellis SG, Topol EJ. Outcomes in African Americans and whites after percutaneous coronary intervention. Am J Med. 2005;118(9):1019-1025.
7. Peterson ED, Shaw LK, DeLong ER, Pryor DB, Califf RM, Mark DB. Racial variation in the use of coronary-revascularization procedures: are the differences real? do they matter? N Engl J Med. 1997;336(7):480-486.
8. Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians’ recommendations for cardiac catheterization. N Engl J Med. 1999;340(8):618-626.
9. Kumar RS, Douglas PS, Peterson ED, et al. Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and Centers for Medicare & Medicaid Services payer databases. Circulation. 2013;127(13):1395-1403.
10. Carlisle DM, Leake BD, Shapiro MF. Racial and ethnic disparities in the use of cardiovascular procedures: associations with type of health insurance. Am J Public Health. 1997;87(2):263-267.
11. Peterson ED, Wright SM, Daley J, Thibault GE. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs. JAMA. 1994;271 (15):1175-1180.
12. Sedlis SP, Fisher VJ, Tice D, Esposito R, Madmon L, Steinberg EH. Racial differences in performance of invasive cardiac procedures in a Department of Veterans Affairs Medical Center. J Clin Epidemiol. 1997;50(8):899-901.
13. Whittle J, Conigliaro J, Good CB, Lofgren RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. N Engl J Med. 1993;329(9):621-627.
14. Mathews R, Chen AY, Thomas L, et al. Differences in short-term vs long-term outcomes of older black vs white patients with myocardial infarction: findings from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of American College of Cardiology/American Heart Association Guidelines (CRUSADE). Circulation. 2014;130(8):659-667.
15. Byrd JB, Vigen R, Plomondon ME, et al. Data quality of an electronic health record tool to support VA cardiac catheterization laboratory quality improvement: the VA Clinical Assessment, Reporting, and Tracking System for Cath Labs (CART) program. Am Heart J. 2013;165(3):434-440.
16. Brindis RG, Fitzgerald S, Anderson HV, Shaw RE, Weintraub WS, Williams JF. The American College of Cardiology–National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol. 2001;37(8): 2240-2245.
17. Anderson HV, Shaw RE, Brindis RG, et al; The American College of Cardiology–National Cardiovascular Data Registry (ACC-NCDR). A contemporary overview of percutaneous coronary interventions. J Am Coll Cardiol. 2002;39 (7):1096-1103.
18. Maddox TM, Stanislawski MA, Grunwald GK, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312(17): 1754-1763.
19. U.S. Census Bureau. Census regions and divisions of the United States. https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us _regdiv.pdf. Accessed June 1, 2016.
20. University of Michigan Population Studies Center, Institute for Social Research. Zip code characteristics: mean and median household income. http://www.psc.isr.umich.edu/dis/census/Features/tract2zip/. Accessed June 6, 2016.
21. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365-3370.
22. Kobayashi N, Hirano K, Yamawaki M, et al. Ability of fractional flow reserve to predict restenosis after superficial femoral artery stenting. J Endovasc Ther. 2016;23(6):896-902.
23. Miki K, Fujii K, Kawasaki D, et al. Intravascular ultrasound–derived stent dimensions as predictors of angiographic restenosis following nitinol stent implantation in the superficial femoral artery. J Endovasc Ther. 2016;23(3):424-432.
24. Stone NJ, Robinson JG, Lichtenstein AH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25, pt B):2889-2934.
25. Li F, Zaslavsky AM, Landrum MB. Propensity score weighting with multilevel data. Stat Med. 2013;32(19):3373-3387.
26. Generalized Linear Models With Clustering [computer program]. Package “glmmML.” https://cran.r-project.org/web/packages/glmmML/glmmML.pdf. Published May 3, 2017. Accessed June 1, 2016.
27. The R Foundation. The R Project for Statistical Computing. https://www.R-project.org/. Accessed June 6, 2016.
28. Olafiranye O, Akinboboye O, Mitchell JE, Ogedegbe G, Jean-Louis G. Obstructive sleep apnea and cardiovascular disease in blacks: a call to action from the Association of Black Cardiologists. Am Heart J. 2013;165(4):468-476.
29. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al; Endorsed by the American Psychiatric Association. AHA science advisory: depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee to the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care Outcomes Research. Prog Cardiovasc Nurs. 2009;24(1):19-26.
30. Ahmadi N, Hajsadeghi F, Mirshkarlo HB, Budoff M, Yehuda R, Ebrahimi R. Post-traumatic stress disorder, coronary atherosclerosis, and mortality. Am J Cardiol. 2011;108(1):29-33.
31. Mooe T, Franklin KA, Holmström K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med. 2001;164(10, pt 1):1910-1913.
32. Kasai T, Floras JS, Bradley TD. Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation. 2012;126(12):1495-1510.
33. Tang KL, Rashid R, Godley J, Ghali WA. Association between subjective social status and cardiovascular disease and cardiovascular risk factors: a systematic review and meta-analysis. BMJ Open. 2016;6(3):e010137.
34. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation. 1993;88(4, pt 1):1973-1998.
35. Stukel TA, Lucas FL, Wennberg DE. Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare patients with acute myocardial infarction. JAMA. 2005;293(11):1329-1337.
36. Lucas FL, Sirovich BE, Gallagher PM, Siewers AE, Wennberg DE. Variation in cardiologists’ propensity to test and treat: is it associated with regional variation in utilization? Circ Cardiovasc Qual Outcomes. 2010;3(3):253-260.
37. Cohen MG, Fonarow GC, Peterson ED, et al. Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines–Coronary Artery Disease program. Circulation. 2010;121(21):2294-2301.
38. Rhoads KF, Patel MI, Ma Y, Schmidt LA. How do integrated health care systems address racial and ethnic disparities in colon cancer? J Clin Oncol. 2015;33(8):854-860.
39. Ayanian JZ, Landon BE, Newhouse JP, Zaslavsky AM. Racial and ethnic disparities among enrollees in Medicare Advantage plans. N Engl J Med. 2014;371(24):2288-2297.
40. Xue JL, Daniels F, Star RA, et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17(4):1135-1142.
41. Rao SV, Shaw RE, Brindis RG, et al. Patterns and outcomes of drug-eluting coronary stent use in clinical practice. Am Heart J. 2006;152(2):321-326.
42. Hannan EL, Racz M, Walford G, et al. Differences in utilization of drug-eluting stents by race and payer. Am J Cardiol. 2007;100(8):1192-1198.
43. Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009;119 (25):3198-3206.
44. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension, II: results of long-term therapy. JAMA. 1982;248(16):2004-2011.
45. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension, I: results of short-term titration with emphasis on racial differences in response. JAMA. 1982;248(16):1996-2003.
46. Preston RA, Materson BJ, Reda DJ, et al; Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. JAMA. 1998;280(13):1168-1172.
47. Andersson C, Shilane D, Go AS, et al. β-Blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease. J Am Coll Cardiol. 2014;64(3):247-252.
48. Bangalore S, Bhatt DL, Steg PG, et al. β-Blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial. Circ Cardiovasc Qual Outcomes. 2014;7(6):872-881.
49. Bangalore S, Steg G, Deedwania P, et al; REACH Registry Investigators. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): 1340-1349.